Witnessing the stock’s movement on the chart, on April 07, 2021, Twist Bioscience Corporation (NASDAQ: TWST) had a quiet start as it plunged -0.79% to $127.64. During the day, the stock rose to $130.29 and sunk to $123.79 before settling in for the price of $128.65 at the close. Taking a more long-term approach, TWST posted a 52-week range of $25.72-$214.07.
Nevertheless, stock’s Earnings Per Share (EPS) this year is 8.90%. This publicly-traded company’s shares outstanding now amounts to $46.00 million, simultaneously with a float of $45.39 million. The organization now has a market capitalization sitting at $6.29 billion. At the time of writing, stock’s 50-day Moving Average stood at $143.47, while the 200-day Moving Average is $105.76.
If we measure the efficiency of the company that is accounted for 525 employees. It has generated 171,619 per worker during the last fiscal year. Meanwhile, its income per employee was -266,535. The stock had 4.68 Receivables turnover and 0.31 Total Asset turnover. For the Profitability, stocks gross margin was +31.85, operating margin was -130.50 and Pretax Margin of -154.88.
Twist Bioscience Corporation (TWST) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Diagnostics & Research industry. Twist Bioscience Corporation’s current insider ownership accounts for 2.10%, in contrast to 89.50% institutional ownership. According to the most recent insider trade that took place on Apr 05, this organization’s Chief Commercial Officer sold 2,702 shares at the rate of 126.72, making the entire transaction reach 342,397 in total value, affecting insider ownership by 42,744. Preceding that transaction, on Mar 29, Company’s See Remarks sold 377 for 114.39, making the whole transaction’s value amount to 43,125. This particular insider is now the holder of 66,926 in total.
Twist Bioscience Corporation (TWST) Earnings and Revenue Records
As on 12/30/2020, Multinational firm has announced its last quarter scores, in which it reported -$0.72 earnings per share (EPS) for the period topping the consensus outlook (set at -$0.74) by $0.02. This company achieved a net margin of -155.31 while generating a return on equity of -57.31. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.78 per share during the current fiscal year.
Twist Bioscience Corporation’s EPS increase for this current 12-month fiscal period is 8.90% and is forecasted to reach -2.86 in the upcoming year.
Twist Bioscience Corporation (NASDAQ: TWST) Trading Performance Indicators
Let’s observe the current performance indicators for Twist Bioscience Corporation (TWST). It’s Quick Ratio in the last reported quarter now stands at 16.70. The Stock has managed to achieve an average true range (ATR) of 12.44. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 62.25.
In the same vein, TWST’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.79, a figure that is expected to reach -0.77 in the next quarter, and analysts are predicting that it will be -2.86 at the market close of one year from today.
Technical Analysis of Twist Bioscience Corporation (TWST)
Going through the that latest performance of [Twist Bioscience Corporation, TWST]. Its last 5-days volume of 1.03 million indicated improvement to the volume of 1.03 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 78.32% While, its Average True Range was 11.57.
Raw Stochastic average of Twist Bioscience Corporation (TWST) in the period of the previous 100 days is set at 26.00%, which indicates a major fall in contrast to 64.51% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 106.30% that was lower than 109.68% volatility it exhibited in the past 100-days period.